Risk Factors for Unfavorable Functional Outcome after Endovascular Treatment of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage

References

1. 1.↵
   1. Harrod CG,
   2. Bendok BR,
   3. Batjer HH

   . Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery 2005;56:633–54 doi:10.1227/01.neu.0000156644.45384.92 pmid:15792502

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Vergouwen MD,
   2. Ilodigwe D,
   3. Macdonald RL

   . Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects. Stroke 2011;42:924–29 doi:10.1161/STROKEAHA.110.597914 pmid:21311062

   Abstract/FREE Full Text
3. 3.↵
   1. Hoh BL,
   2. Ko NU,
   3. Amin-Hanjani S, et al

   . 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke 2023;54:e314–70 doi:10.1161/STR.0000000000000436 pmid:37212182

   CrossRefPubMed
4. 4.↵
   1. Kwon H-J,
   2. Lim J-W,
   3. Koh H-S, et al

   . Stent-retriever angioplasty for recurrent post-subarachnoid hemorrhagic vasospasm—a single center experience with long-term follow-up. Clin Neuroradiol 2019;29:751–61 doi:10.1007/s00062-018-0711-3 pmid:30083794

   CrossRefPubMed
5. 5.↵
   1. Salem MM,
   2. Khalife J,
   3. Desai S, et al

   . COManeci MechANical dilation for vasospasm (COMMAND): multicenter experience. J Neurointerv Surg 2022;15:864–70 doi:10.1136/jnis-2022-019272 pmid:36002289

   CrossRefPubMed
6. 6.↵
   1. Hosmann A,
   2. Rauscher S,
   3. Wang W-T, et al

   . Intra-arterial papaverine-hydrochloride and transluminal balloon angioplasty for neurointerventional management of delayed-onset post-aneurysmal subarachnoid hemorrhage vasospasm. World Neurosurg 2018;119:e301–12 doi:10.1016/j.wneu.2018.07.138 pmid:30053563

   CrossRefPubMed
7. 7.↵
   1. Kimball MM,
   2. Velat GJ,
   3. Hoh BL

   , Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Critical care guidelines on the endovascular management of cerebral vasospasm. Neurocrit Care 2011;15:336–41 doi:10.1007/s12028-011-9600-1 pmid:21761272

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Vatter H,
   2. Güresir E,
   3. König R, et al

   . Invasive diagnostic and therapeutic management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage (IMCVS)-a phase 2 randomized controlled trial. J Clin Med 2022;11:6197 doi:10.3390/jcm11206197

   CrossRefPubMed
9. 9.↵
   1. Boulouis G,
   2. Labeyrie MA,
   3. Raymond J, et al

   . Treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis. Eur Radiology 2017;27:3333–42 doi:10.1007/s00330-016-4702-y pmid:28004163

   CrossRefPubMed
10. 10.↵
    1. von Elm E,
    2. Altman DG,
    3. Egger M

    ; STROBE Initiative, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 2014;12:1495–99 doi:10.1016/j.ijsu.2014.07.013 pmid:25046131

    CrossRefPubMed
11. 11.↵
    1. Mitchelle A,
    2. Gorolay VV,
    3. Aitken M, et al

    . CTP for the screening of vasospasm and delayed cerebral ischemia in aneurysmal SAH: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2024;45:871–78 doi:10.3174/ajnr.A8249

    Abstract/FREE Full Text
12. 12.↵
    1. Vergouwen MDI,
    2. Vermeulen M,
    3. van Gijn J, et al

    . Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 2010;41:2391–95 doi:10.1161/STROKEAHA.110.589275

    Abstract/FREE Full Text
13. 13.↵
    1. Dodd WS,
    2. Laurent D,
    3. Dumont AS, et al

    . Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review. J Am Heart Assoc 2021;10:e021845 doi:10.1161/JAHA.121.021845 pmid:34325514

    CrossRefPubMed
14. 14.↵
    1. Vergouwen MD,
    2. Vermeulen M,
    3. Coert BA, et al

    . Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 2008;28:1761–70 doi:10.1038/jcbfm.2008.74 pmid:18628782

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Rosengart AJ,
    2. Schultheiss KE,
    3. Tolentino J, et al

    . Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 2007;38:2315–21 doi:10.1161/STROKEAHA.107.484360 pmid:17569871

    Abstract/FREE Full Text
16. 16.↵
    1. Rubbert C,
    2. Patil KR,
    3. Beseoglu K, et al

    . Prediction of outcome after aneurysmal subarachnoid haemorrhage using data from patient admission. Eur Radiology 2018;28:4949–58 doi:10.1007/s00330-018-5505-0 pmid:29948072

    CrossRefPubMed
17. 17.↵
    1. Lidington D,
    2. Wan H,
    3. Bolz SS

    . Cerebral autoregulation in subarachnoid hemorrhage. Front Neurol 2021;12:688362 doi:10.3389/fneur.2021.688362 pmid:34367053

    CrossRefPubMed
18. 18.↵
    1. Schmidt TP,
    2. Weiss M,
    3. Hoellig A, et al

    . Revisiting the timeline of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: toward a temporal risk profile. Neurocrit Care 2022;37:735–43 doi:10.1007/s12028-022-01545-9 pmid:35790670

    CrossRefPubMed
19. 19.↵
    1. Bendszus M,
    2. Stoll G

    . Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol 2006;5:364–72 doi:10.1016/S1474-4422(06)70412-4 pmid:16545753

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Cole TS,
    2. Rudy RF,
    3. Faridmoayer E, et al

    . Relationship between cerebral vasospasm vascular territory and functional outcome after aneurysmal subarachnoid hemorrhage. J Neurointerv Surg 2023;15:958–63 doi:10.1136/jnis-2022-019016 pmid:36379702

    Abstract/FREE Full Text
21. 21.↵
    1. Andereggen L,
    2. Beck J,
    3. Z’Graggen WJ, et al

    . Feasibility and safety of repeat instant endovascular interventions in patients with refractory cerebral vasospasms. AJNR Am J Neuroradiol 2017;38:561–67 doi:10.3174/ajnr.A5024 pmid:27979797

    Abstract/FREE Full Text
22. 22.↵
    1. Ditz C,
    2. Neumann A,
    3. Wojak J, et al

    . Repeated endovascular treatments in patients with recurrent cerebral vasospasms after subarachnoid hemorrhage: a worthwhile strategy? World Neurosurg 2018;112:e791–98 doi:10.1016/j.wneu.2018.01.156 pmid:29410034

    CrossRefPubMed
23. 23.↵
    1. Jabbarli R,
    2. Pierscianek D,
    3. Rölz R, et al

    . Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhage: more is more. Neurology 2019;93:e458–66 doi:10.1212/WNL.0000000000007862 pmid:31278116

    CrossRefPubMed
24. 24.↵
    1. Vossen LV,
    2. Weiss M,
    3. Albanna W, et al

    . Intra-arterial nimodipine for the treatment of refractory delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurointerv Surg Epub ahead of print Feb 13, 2024
25. 25.↵
    1. Lim J,
    2. Cho YD,
    3. Byoun HS

    . Comparative study of vasodilatation after intra-arterial nicardipine or dantrolene infusion in animal model of cerebral vasospasm. Clin Neuroradiol 2022;32:1011–17 doi:10.1007/s00062-022-01151-4 pmid:35294572

    CrossRefPubMed
26. 26.↵
    1. Adami D,
    2. Berkefeld J,
    3. Platz J, et al

    . Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: worth the risk? J Neuroradiol 2019;46:15–24 doi:10.1016/j.neurad.2018.04.001 pmid:29733918

    CrossRefPubMed